# TRV GP II, LLC

> Institutional holdings reported to the SEC as of Q3 2022 on Form 13F. CIK 1614073. Source: https://holderbook.com/funds/1614073-trv-gp-ii-llc/

- Reported value: $1.3M
- Positions: 1
- Weight of the ten largest: 100.0%
- Filed: 2022-11-03

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| JOUNCE THERAPEUTICS INC | [JNCE](https://holderbook.com/stocks/JNCE/) | $1.3M | 572,829 | 100.0% | 16 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2022 | $1.3M | 1 |
| Q2 2022 | $4.6M | 2 |
| Q1 2022 | $9.8M | 2 |
| Q4 2021 | $24.2M | 2 |
| Q3 2021 | $22.6M | 2 |
| Q2 2021 | $33.9M | 2 |
| Q1 2021 | $158.2M | 3 |
| Q4 2020 | $143.6M | 3 |
| Q3 2020 | $154.1M | 3 |
| Q2 2020 | $135.3M | 3 |
| Q1 2020 | $93.1M | 3 |
| Q4 2019 | $96.9M | 2 |